EUVIMEDEUVIMED entdecken
Crossref

Clinicopathological phenotype and outcomes of NCAM-1+ membranous lupus nephritis

Xi Xia iD, Suchun Li, Xiuzhi Jia, Siyang Ye, Yuting Fan iD, Wang Xiang, Xiaohui Lu, Wenxing Peng, Wenfang Chen, Fengxian Huang, Ruihan Tang iD, Wei Chen iD

Nephrology Dialysis Transplantation · 2024

DOI: 10.1093/ndt/gfae148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2024. Verfasst von Xi Xia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: CD56 Antigen, Lupus Nephritis, Phenotype. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

No studies have explored the long-term outcomes of neural cell adhesion molecule 1 (NCAM1)-associated membranous lupus nephritis (MLN) patients.

Method

We performed immunohistochemical studies on kidney biopsy specimens against NCAM1 in consecutive MLN patients. The clinical and histopathological characteristics and outcomes of cases of NCAM1-associated MLN patients are described and compared with NCAM1-negative patients. In addition, we detected serum circulating anti-NCAM1 antibodies through western blotting and indirect immunofluorescence assays.

Results

Among 361 MLN cases, 18 (5.0%) were glomerular NCAM1-positive. NCAM1-positive MLN patients were older [35 years (interquartile range, IQR 27–43) versus 28 (22–37); P = .050] and had lower systemic lupus erythematosus disease activity index [11 (IQR 8–12) versus 14 (10–18); P = .007], serum creatinine [60 μmol/L (IQR 50–70) versus 70 (54–114); P = .029] and activity index [3 (IQR 2–6) versus 6 (3–9); P = .045] at kidney biopsy compared with NCAM1-negative patients. The percentage of positive anti-Sjögren's syndrome–related antigen A antibodies in NCAM1-positive patients was significantly greater (83.3% versus 58.2%; P = .035) than in the NCAM1-negative patients. However, no evidence of neuropsychiatric disorders was found in these 18 patients. There were no significant differences in the treatment response and the risk of end-stage renal diseases between NCAM1-positive and -negative groups (P = .668 and P = .318, respectively). However, the risk of death was much higher in the NCAM1-positive group than the NCAM1-negative group (27.8% vs 8.1%; P = .007). Moreover, the risk of death was also much higher in the NCAM1-positive group than the matched NCAM1-negative group (Log-rank P = .013). Additionally, circulating anti-NCAM1 antibodies can be detected in 1/5 (20%) patients who had serum available.

Conclusion

The prevalence of NCAM1 positivity was 5.0% in our cohort of MLN and the high mortality in these subgroup patients are needed to validate in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD56 AntigenLupus NephritisPhenotypeHumansFemaleMaleAdultPrognosisFollow-Up StudiesGlomerulonephritis, MembranousMiddle AgedBiomarkersAutoantibodies

Stichwörter der Autor:innen

lupus nephritismembranous nephropathyneural cell adhesion molecule 1target autoantigen

Substanzen

CD56 AntigenNCAM1 protein, humanBiomarkersAutoantibodies

Autor:innen und Institutionen

  • Department of Nephrology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
  • NHC Key Laboratory of Clinical Nephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, People's Republic of China.
  • Department of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.

ORCID-Profile: Xi Xia, Yuting Fan, Ruihan Tang, Wei Chen

Förderung

  • National Natural Science Foundation of China
  • National Health Commission

Zitieren

APA

Xia, X., Li, S., Jia, X., Ye, S., Fan, Y., Xiang, W., Lu, X., Peng, W., Chen, W., Huang, F., Tang, R., & Chen, W. (2024). Clinicopathological phenotype and outcomes of NCAM-1+ membranous lupus nephritis. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfae148

Vancouver

Xia X, Li S, Jia X, Ye S, Fan Y, Xiang W, et al. Clinicopathological phenotype and outcomes of NCAM-1+ membranous lupus nephritis. Nephrology Dialysis Transplantation. 2024. doi:10.1093/ndt/gfae148

BibTeX
@article{Xia2024,
  author = {Xia, Xi and Li, Suchun and Jia, Xiuzhi and Ye, Siyang and Fan, Yuting and Xiang, Wang and Lu, Xiaohui and Peng, Wenxing and Chen, Wenfang and Huang, Fengxian and Tang, Ruihan and Chen, Wei},
  title = {Clinicopathological phenotype and outcomes of NCAM-1+ membranous lupus nephritis},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  doi = {10.1093/ndt/gfae148}
}
Kostenlos starten →